CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-07 | Gallagher Cam Director | Sale | −9,477 | $44.90 | $426K | 376,336 |
| 2022-03-07 | Gallagher Cam Director | Sale | −523 | $45.56 | $24K | 375,813 |
| 2022-03-02 | SUN ANTHONY Y President & CEO | Sale | −9,771 | $50.11 | $490K | 1,197,231 |
| 2022-03-02 | SUN ANTHONY Y President & CEO | Sale | −700 | $50.91 | $36K | 1,196,531 |
| 2022-03-01 | SUN ANTHONY Y President & CEO | Sale | −8,771 | $49.74 | $436K | 1,208,702 |
| 2022-03-01 | SUN ANTHONY Y President & CEO | Sale | −1,700 | $50.05 | $85K | 1,207,002 |
| 2022-02-23 | Epperly Melissa B, Chief Financial Officer | Sale | −1,211 | $48.81 | $59K | 265,196 |
| 2022-02-23 | Epperly Melissa B, Chief Financial Officer | Sale | −702 | $49.59 | $35K | 264,494 |
| 2022-02-22 | Bunker Kevin D. Chief Operating Officer | Sale | −800 | $47.08 | $38K | 169,200 |
| 2022-02-22 | Bunker Kevin D. Chief Operating Officer | Sale | −6,343 | $48.95 | $310K | 162,857 |
| 2022-02-22 | Bunker Kevin D. Chief Operating Officer | Sale | −2,451 | $49.92 | $122K | 160,406 |
| 2022-02-22 | Bunker Kevin D. Chief Operating Officer | Sale | −406 | $50.39 | $20K | 160,000 |
| 2022-02-15 | Gallagher Cam Director | Sale | −3,264 | $51.22 | $167K | 392,549 |
| 2022-02-15 | Gallagher Cam Director | Sale | −5,366 | $52.15 | $280K | 387,183 |
| 2022-02-15 | Gallagher Cam Director | Sale | −1,370 | $52.74 | $72K | 385,813 |
| 2022-02-14 | Bunker Kevin D. Chief Operating Officer | Sale | −1,622 | $50.16 | $81K | 767,176 |
| 2022-02-14 | Bunker Kevin D. Chief Operating Officer | Sale | −203 | $50.75 | $10K | 766,973 |
| 2022-02-14 | Bunker Kevin D. Chief Operating Officer | Sale | −2,863 | $50.29 | $144K | 764,110 |
| 2022-02-14 | Voliotis Dimitris SVP, Clinical Development | Sale | −534 | $50.16 | $27K | 16,045 |
| 2022-02-14 | Voliotis Dimitris SVP, Clinical Development | Sale | −67 | $50.75 | $3K | 15,978 |
Page 10 of 28 · 545 trades